 |
|
Teens overlooked in cancer research
January 05, 2007McMaster University pediatric cancer specialist Dr. Ronald Barr says the teen gap in cancer care has been overlooked for far too long.
Statistics show that gains in survival rates for teenagers and young adults (age 15-29) with cancer are dismal when compared to those for youngsters and older adults with the disease.
"While there have been improvements in survival in children and older adults in recent decades there has been no such improvement in this age group in the past 25 years or so," said Barr, a professor of pediatrics of the Michael G. DeGroote School of Medicine at McMaster University and chief of hematology-oncology at McMaster Children's Hospital.
Barr, who is involved in local, national and international efforts to reverse this trend, is available for interviews to discuss this issue.
Barr is one of the editors of the recently released and first definitive document on the incidence, survival and mortality of 15-29 year-olds. Funded by the National Cancer Institute (NCI) in the United States, this monograph was a co-operative venture between the Children's Oncology Group (all 17 pediatric oncology centers in Canada and more than 200 American institutions) and the SEER (Survival Epidemiology and End Results) program.
Barr is a member of the NCI and Lance Armstrong Foundation's new Progress Review Group whose sole purpose is identifying and prioritizing the scientific, medical and psychosocial barriers facing adolescent and young adult (AYA) cancer patients. They plan to develop strategies to better the odds for this age group.
"The Lance Armstrong Foundation is very keen to advocate for young people with cancer and educate them in high schools, colleges and work places to the fact cancer can afflict people in their age group-and that when they get a lump they shouldn't say 'it's just a lump' but that it might be a form of cancer," Barr said.
Barr co-chairs the Working Group on AYA within the International Society for Pediatric Oncology which will soon publish proceedings from its first workshop on AYA adolescent and young adults with cancer. He is also one of the authors and editors of an upcoming book on this issue.
He said there are a variety of reasons why the outlook is so poor for this particular age group. Chief among them is the fact so few are participating in clinical trials-organized studies which test the value of various treatments, such as drugs or surgery in human beings. This lack of involvement correlates directly with their poor survival rates, he said.
Young people's feelings of invincibility, coupled with a lack of awareness about their cancer risk, are other factors. And often family physicians aren't suspicious enough of teenagers' symptoms, interpreting a lump in the neck as an infection or leg pain as an athletic injury or growing pains, which delays an accurate diagnosis.
Even more confusing, Barr said, is the fact that the types of cancer within the 15-29 age group occur at different frequencies across this age range, the most common types in teenagers being different from the most common types in young adults.
McMaster University
Barr, who is involved in local, national and international efforts to reverse this trend, is available for interviews to discuss this issue.
Barr is one of the editors of the recently released and first definitive document on the incidence, survival and mortality of 15-29 year-olds. Funded by the National Cancer Institute (NCI) in the United States, this monograph was a co-operative venture between the Children's Oncology Group (all 17 pediatric oncology centers in Canada and more than 200 American institutions) and the SEER (Survival Epidemiology and End Results) program.
Barr is a member of the NCI and Lance Armstrong Foundation's new Progress Review Group whose sole purpose is identifying and prioritizing the scientific, medical and psychosocial barriers facing adolescent and young adult (AYA) cancer patients. They plan to develop strategies to better the odds for this age group.
"The Lance Armstrong Foundation is very keen to advocate for young people with cancer and educate them in high schools, colleges and work places to the fact cancer can afflict people in their age group-and that when they get a lump they shouldn't say 'it's just a lump' but that it might be a form of cancer," Barr said.
Barr co-chairs the Working Group on AYA within the International Society for Pediatric Oncology which will soon publish proceedings from its first workshop on AYA adolescent and young adults with cancer. He is also one of the authors and editors of an upcoming book on this issue.
He said there are a variety of reasons why the outlook is so poor for this particular age group. Chief among them is the fact so few are participating in clinical trials-organized studies which test the value of various treatments, such as drugs or surgery in human beings. This lack of involvement correlates directly with their poor survival rates, he said.
Young people's feelings of invincibility, coupled with a lack of awareness about their cancer risk, are other factors. And often family physicians aren't suspicious enough of teenagers' symptoms, interpreting a lump in the neck as an infection or leg pain as an athletic injury or growing pains, which delays an accurate diagnosis.
Even more confusing, Barr said, is the fact that the types of cancer within the 15-29 age group occur at different frequencies across this age range, the most common types in teenagers being different from the most common types in young adults.
McMaster University
Cancer Research Current Events and Cancer Research News RSSResearchers Identify Role of Gene in Tumor Development, Growth and Progression
Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis.
Gene mismatch influences success of bone marrow transplants
A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics.
Common pain relief medication may encourage cancer growth
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning.
'Cross-talk' mechanism contributes to colorectal cancer
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors.
No-entry zones for AIDS virus
The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.
Quarter of a million children in England at risk of skin cancer from sunbeds
An estimated quarter of a million 11-17 year olds in England are being put at increased risk of developing malignant melanoma by using sunbeds, warn researchers in a letter to this week's BMJ.
Iowa State University researcher discovers key to vital DNA, protein interaction
A researcher at Iowa State University has discovered how a group of proteins from plant pathogenic bacteria interact with DNA in the plant cell, opening up the possibility for what the scientist calls a "cascade of advances."
New mechanism explains how the body prevents formation of blood vessels
Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels.
Newly Discovered Fat Molecule: An Undersea Killer with an Upside
A chemical culprit responsible for the rapid, mysterious death of phytoplankton in the North Atlantic Ocean has been found by collaborating scientists at Rutgers University and the Woods Hole Oceanographic Institution (WHOI). This same chemical may hold unexpected promise in cancer research.
More Cancer Research Current Events and Cancer Research News Articles
 |
Master Lock 1534DPNK Breast Cancer Research Foundation Password Lock, Pink by Master Lock |
 |
The Secret History of the War on Cancer by Devra Davis (Author) Why has the “War on Cancer” languished, focusing mainly on finding and treating the disease and downplaying the need to control and combat cancer’s basic causes—tobacco, the workplace, radiation, and the general environment? This war has targeted the wrong enemies with the wrong weapons, failing to address well-known cancer causes. As epidemiologist Devra Davis shows in this superbly researched exposé, this is no accident. The War on Cancer has followed the commercial interests of industries that generated a host of cancer-causing materials and products. This is the gripping story of a major public health effort diverted and distorted for private gain that is being reclaimed through efforts to green health care and the environment. |
 |
Master Lock 1530DPNK Breast Cancer Research Foundation Dial Combination Lock, Pink by Master Lock |
 |
Life Bear (small) 12" by Gund 74950 by Gund The Life Bear is made of an incredible silky pink fur that is almost iridescent. She features a satin-stitched nose and the LIFE logo on her left foot as well as a sheer pink ribbon around her neck. The Val Skinner Foundation and GUND have joined forces to develop the LIFE Bear (LPGA Pros In the Fight to Eradicate Breast Cancer). A portion of the proceeds of the sale of these bears will support the Val Skinner Foundation's breast cancer initiatives. Each bear has embroidered on her foot the 'LIFE' logo. |
|
Annals of Cancer Research and Therapy by Pjd Publs Ltd | |
 |
Little Pink Drill $49-10% Donated to Breast Cancer Research! by Little Pink Tools 18 volt cordless rechargable drill specifically designed for women. Attractive and lightweight at only 3.25 lbs. Perfect for all your home maintenance! 1 year guarantee on drill, batteries and charger. |
 |
L'Oréal Paris Color of Hope OCRF (Ovarian Cancer Research Fund) Fundraising Sterling Silver Pavé CZ Bracelet by Netaya Sterling beauty with an equally beautiful message. Its new, its exclusive and its absolutely beautiful. LOreal Paris is proud to present the Color of Hope Bracelet, a fundraising campaign, with 100% of all net profits ($5.00 per bracelet) benefiting The Ovarian Cancer Research Fund (OCRF). Whether viewed as a circle representing life, endurance, love or seen as an "O" for ovarian cancer, the bracelet is a simple way for women everywhere to visibly and tangibly help in the fight against one of the world's most deadly of women's cancers. The exclusive sterling silver Color of Hope bracelet features a rolo design chain with an "O" toggle clasp, adorned with pave cubic zirconias to give a beautiful brilliance. And to ensure that all women can adorn their wrists, the bracelet... |
 |
Nova - Cancer Warrior Starring: Liev Schreiber Directed By: Nancy Linde Studio: Wgbh Wholesale Release Date: 10/02/2001 Run time: 60 minutes |
 |
Atlanta Braves Ladies Black Breast Cancer Research Logo T-shirt by Football Fanatics Join Major League Baseball in the fight against breast cancer with this special edition breast cancer research team logo tee! Part of the proceeds from the sale of this tee will be donated to the Susan G. Komen Breast Cancer Foundation, so make sure you do your part! |
 |
Pink PedEgg For Breast Cancer Research Foundation!! |
| © 2009 BrightSurf.com |